OpenCell Biomed, Inc. OCBM Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
OpenCell Biomed, Inc. OCBM Company Overview 

Stock Message Board http://investorshangout.com/search?q=OCBM&...mp;yt1=Go!

OpenCell Biomed, Inc. OCBM Current Price and Quotes
Last Price 0.007
Previous Close 0.007 Open N/A
Daily Range N/A - N/A 52wk Range 0.05 - 0.0008
Volume 0 Dividend N/A
Average Vol (3m) 30,893 Yield N/A
OpenCell Biomed, Inc. OCBM
Company Information

25 The West Mall
#253, Unit 1336
Toronto, ONT M9C 1B8
Canada

Phone: 416-622-5354

OpenCell Biomed, Inc. OCBM
OpenCell Biomed, Inc. OCBM
Financial Reportings and Disclosures

Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Nov 14, 2011
Audited Financials Not Available
Latest Report Aug 31, 2011 10-Q
CIK 0001385596
Fiscal Year End 11/30
OTC Marketplace OTC Pink No Information
Profile Data

SIC - Industry Classification 8742 - Management consulting services
Incorporated In: NV, USA
Year of Inc. 2006
Employees Not Available
Company Officers/Contacts

Janetta Voitenkova President, CEO
Nikolay Bulbash CFL, Secretary, Treasurer
Company Directors

Nikolay Bulbash
Mislav Pavelic
Company Notes

Formerly=Grand Motion, Inc. until 9-2008
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

OpenCell Biomed, Inc. OCBM
OCBM Security Details

Share Structure

Market Value1 $182,980 a/o Sep 13, 2013
Shares Outstanding 26,140,000 a/o Jul 14, 2008
Float Not Available
Authorized Shares Not Available
Par Value  0.0001
Shareholders

Shareholders of Record 12 a/o Nov 11, 2011
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Apr 03, 2008 Mar 21, 2008 Apr 02, 2008
Security Notes

Capital Change=shs increased by 2 for 1 split. Ex-date=04/03/2008. Rec date=03/21/2008. Pay date=04/02/2008.
Short Selling Data

Short Interest 0 (-100%)
Jan 15, 2010
Significant Failures to Deliver  No
Transfer Agent(s)

Island Stock Transfer

OpenCell Biomed, Inc. OCBM Recent News

OpenCell Biomed, Inc. OCBM Financials
OCBM


OCBM OpenCell Biomed, Inc. Research DD Guide

OCBM OpenCell Biomed, Inc. Stock Message Board http://investorshangout.com/search?q=OCBM&...mp;yt0=Go!
OCBM OpenCell Biomed, Inc. Stock Quote http://www.otcmarkets.com/stock/OCBM/quote
OCBM OpenCell Biomed, Inc. Stock Chart http://www.otcmarkets.com/stock/OCBM/chart
OCBM OpenCell Biomed, Inc. Company Info http://www.otcmarkets.com/stock/OCBM/company-info
OCBM OpenCell Biomed, Inc. Recent News http://www.otcmarkets.com/stock/OCBM/news
OCBM OpenCell Biomed, Inc. Financials http://www.otcmarkets.com/stock/OCBM/financials
OCBM OpenCell Biomed, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/OCBM/filings
OCBM OpenCell Biomed, Inc. Short Sales http://www.otcmarkets.com/stock/OCBM/short-sales
OCBM OpenCell Biomed, Inc. Insider Disclosure http://www.otcmarkets.com/stock/OCBM/insider-transactions
OCBM OpenCell Biomed, Inc. Research Reports http://www.otcmarkets.com/stock/OCBM/research
OCBM OpenCell Biomed, Inc. Summary http://finance.yahoo.com/q?s=OCBM
OCBM OpenCell Biomed, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=OCBM+Historical+Prices
OCBM OpenCell Biomed, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=OCBM
OCBM OpenCell Biomed, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=OCBM+Basic+Chart
OCBM OpenCell Biomed, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=OCBM+Basic+Tech.+Analysis
OCBM OpenCell Biomed, Inc. Headlines http://finance.yahoo.com/q/h?s=OCBM+Headlines
OCBM OpenCell Biomed, Inc. Press Releases http://finance.yahoo.com/q/p?s=OCBM+Press+Releases
OCBM OpenCell Biomed, Inc. Company Profile http://finance.yahoo.com/q/pr?s=OCBM+Profile
OCBM OpenCell Biomed, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=OCBM+Key+Statistics
OCBM OpenCell Biomed, Inc. Industry http://finance.yahoo.com/q/in?s=OCBM+Industry
OCBM OpenCell Biomed, Inc. Major Holders http://finance.yahoo.com/q/mh?s=OCBM+Major+Holders
OCBM OpenCell Biomed, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=OCBM+Insider+Transactions
OCBM OpenCell Biomed, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=OCBM+Insider+Roster
OCBM OpenCell Biomed, Inc. Income Statement http://finance.yahoo.com/q/is?s=OCBM
OCBM OpenCell Biomed, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=OCBM
OCBM OpenCell Biomed, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=OCBM+Cash+Flow&annual
OCBM OpenCell Biomed, Inc. Nasdaq http://www.nasdaq.com/symbol/OCBM
OCBM OpenCell Biomed, Inc. Market Watch http://www.marketwatch.com/investing/stock/OCBM
OCBM OpenCell Biomed, Inc. Bloomberg http://www.bloomberg.com/quote/OCBM:US
OCBM OpenCell Biomed, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=OCBM
OCBM OpenCell Biomed, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=OCBM
OCBM OpenCell Biomed, Inc. Barchart http://www.barchart.com/quotes/stocks/OCBM
OCBM OpenCell Biomed, Inc. OTC Short Report http://otcshortreport.com/index.php?index=OCBM
OCBM OpenCell Biomed, Inc. Investopedia http://www.investopedia.com/markets/stocks/OCBM/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 126

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 253

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 313

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 206

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 126

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 231

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading

Top 5 Most Recently Viewed Articles

Viatris Launches Cash Tender Offers for Outstanding Notes

Updated Category News Views 56

Viatris Launches Cash Tender Offers for Outstanding Notes Viatris Inc. (NASDAQ: VTRS), a leading player in the global healthcare sector, has initiated tender offers to acquire certain outstanding notes. This move is designed to strengthen its financial framework and enhance returns for its shareholders. Notably, the offers include various senior notes that were originally...

Continue Reading
Coke Florida Launches Joyful Holiday Caravan Across Florida

Updated Category News Views 239

Coke Florida Kicks Off Holiday Spirit with Caravan Tour Coca-Cola Beverages Florida, LLC (Coke Florida) is thrilled to share that its beloved annual "Holiday Caravan" is set to return. This event, which has become an essential part of the holiday season, features the iconic Coca-Cola red delivery truck decked out in festive cheer. Families will enjoy complimentary samples...

Continue Reading
Nexxen to Join RBC Conference, Share Insights on Technology

Updated Category News Views 68

Nexxen's Upcoming Participation at RBC Global Conference Nexxen International Ltd. (AIM/NASDAQ: NEXN), a leading global advertising technology platform, is geared up to take part in a significant event, the RBC Global Technology, Internet, Media and Telecommunications Conference. This event provides a stellar opportunity for companies to connect with investors and share...

Continue Reading
GayVeterans.us Obtains 501(c)(3) Status to Broaden Support

Updated Category News Views 125

GayVeterans.us Achieves 501(c)(3) Tax Exempt Status GayVeteransUS-Inc. has recently been granted 501(c)(3) tax-exempt status, marking a significant milestone for the organization. This designation enables supporters to make tax-deductible contributions, strengthening the community's ability to provide enhanced resources and support. The dedication of veteran volunteers...

Continue Reading
Virbac Expands Portfolio with Acquisition of Felanorm Solution

Updated Category News Views 130

Virbac Enhances Its Offerings with Felanorm Acquisition Virbac has announced a significant acquisition that marks a pivotal moment in its commitment to improving the health and quality of life for senior cats. This globally recognized drug is aimed at treating feline hyperthyroidism, a condition that is becoming increasingly common in older cats. Understanding Feline...

Continue Reading